24 HR methylphenidate hydrochloride 27 MG Extended Release Oral Tablet [Concerta]
- RxCUI
- 1091172
- RxNorm name
- 24 HR methylphenidate hydrochloride 27 MG Extended Release Oral Tablet [Concerta]
- Display name
- 24 HR methylphenidate hydrochloride 27 MG Extended Release Oral Tablet [Concerta]
- Full name
- 24 HR methylphenidate hydrochloride 27 MG Extended Release Oral Tablet [Concerta]
- Term type
- SBD
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:38:49
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| CONCERTA | METHYLPHENIDATE HYDROCHLORIDE | Janssen Pharmaceuticals, Inc. | 1a88218c-5b18-4220-8f56-526de1a276cd | 2026-04-20 | Boxed warning, Warnings, Adverse reactions | 1091172 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm string | TTY | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 1a88218c-5b18-4220-8f56-526de1a276cd | 24 HR methylphenidate hydrochloride 27 MG Extended Release Oral Tablet [Concerta] | SBD | 30 | These highlights do not include all the information needed to use CONCERTA safely and effectively. See full prescribing information for CONCERTA. CONCERTA ® (methylphenidate hydrochloride) extended-release tablets, for oral use, CII Initial U.S. Approval: 2000 | 20260420 |
| 1a88218c-5b18-4220-8f56-526de1a276cd | CONCERTA 27 MG 24HR Extended Release Oral Tablet | PSN | 30 | These highlights do not include all the information needed to use CONCERTA safely and effectively. See full prescribing information for CONCERTA. CONCERTA ® (methylphenidate hydrochloride) extended-release tablets, for oral use, CII Initial U.S. Approval: 2000 | 20260420 |
| 1a88218c-5b18-4220-8f56-526de1a276cd | Concerta 27 MG 24 HR Extended Release Oral Tablet | SY | 30 | These highlights do not include all the information needed to use CONCERTA safely and effectively. See full prescribing information for CONCERTA. CONCERTA ® (methylphenidate hydrochloride) extended-release tablets, for oral use, CII Initial U.S. Approval: 2000 | 20260420 |
| 1a88218c-5b18-4220-8f56-526de1a276cd | 24 HR Concerta 27 MG Extended Release Oral Tablet | SY | 30 | These highlights do not include all the information needed to use CONCERTA safely and effectively. See full prescribing information for CONCERTA. CONCERTA ® (methylphenidate hydrochloride) extended-release tablets, for oral use, CII Initial U.S. Approval: 2000 | 20260420 |
| f63155b9-ea71-4a30-be32-37173f87bcbf | 24 HR Concerta 27 MG Extended Release Oral Tablet | SY | 1 | These highlights do not include all the information needed to use CONCERTA ® safely and effectively. See full prescribing information for CONCERTA ® . CONCERTA ® (methylphenidate HCl) Extended-Release Tablets CII Initial U.S. Approval: 2000 | 20101101 |
| f63155b9-ea71-4a30-be32-37173f87bcbf | Concerta 27 MG 24 HR Extended Release Oral Tablet | SY | 1 | These highlights do not include all the information needed to use CONCERTA ® safely and effectively. See full prescribing information for CONCERTA ® . CONCERTA ® (methylphenidate HCl) Extended-Release Tablets CII Initial U.S. Approval: 2000 | 20101101 |
| f63155b9-ea71-4a30-be32-37173f87bcbf | CONCERTA 27 MG 24HR Extended Release Oral Tablet | PSN | 1 | These highlights do not include all the information needed to use CONCERTA ® safely and effectively. See full prescribing information for CONCERTA ® . CONCERTA ® (methylphenidate HCl) Extended-Release Tablets CII Initial U.S. Approval: 2000 | 20101101 |
| f63155b9-ea71-4a30-be32-37173f87bcbf | 24 HR methylphenidate hydrochloride 27 MG Extended Release Oral Tablet [Concerta] | SBD | 1 | These highlights do not include all the information needed to use CONCERTA ® safely and effectively. See full prescribing information for CONCERTA ® . CONCERTA ® (methylphenidate HCl) Extended-Release Tablets CII Initial U.S. Approval: 2000 | 20101101 |